Israel Englander Veracyte, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Veracyte, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 335,509 shares of VCYT stock, worth $13.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

335,509

Previous 64,231 422.35%

Holding current value

$13.7 Million

Previous $1.39 Million 720.78%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $5.7 Million - $9.56 Million	271,278 Added 422.35%	335,509 $11.4 Million
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $353,851 - $441,845	18,762 Added 41.26%	64,231 $1.39 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $521,661 - $722,873	24,841 Added 120.42%	45,469 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $151,567 - $220,434	-7,686 Reduced 27.15%	20,628 $567,000
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $2.52 Million - $3.25 Million	-120,399 Reduced 80.96%	28,314 $721,000
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $890,146 - $1.21 Million	43,253 Added 41.01%	148,713 $3.32 Million
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $1.45 Million - $2.84 Million	94,711 Added 881.11%	105,460 $2.5 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $178,218 - $299,897	10,749 New	10,749 $178,000
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $2.83 Million - $5.4 Million	-183,019 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $2.51 Million - $4.86 Million	114,380 Added 166.64%	183,019 $5.05 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $2.48 Million - $3.69 Million	68,639 New	68,639 $2.83 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $7.62 Million - $11.3 Million	-214,023 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $2.32 Million - $3.99 Million	70,453 Added 49.07%	214,023 $8.56 Million
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $5.39 Million - $9.87 Million	-121,229 Reduced 45.78%	143,570 $7.72 Million
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $4.45 Million - $8.48 Million	136,991 Added 107.18%	264,799 $13 Million
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $3.42 Million - $4.56 Million	127,808 New	127,808 $4.15 Million
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $1.93 Million - $2.79 Million	-99,230 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $1.6 Million - $2.99 Million	99,230 New	99,230 $2.41 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $7.54 Million - $10.9 Million	-363,025 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $4.59 Million - $5.95 Million	-192,398 Reduced 34.64%	363,025 $8.71 Million
Q2 2019 Aug 15, 2019	SELL	$22.1 - $28.56 $32.7 Million - $42.3 Million	-1,480,345 Reduced 72.72%	555,423 $15.8 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $26.9 Million - $34.7 Million	1,216,541 Added 148.5%	2,035,768 $15.5 Million
Q1 2019 May 14, 2019	SELL	$12.0 - $25.76 $7.19 Million - $15.4 Million	-599,059 Reduced 42.24%	819,227 $20.5 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $5.81 Million - $9.42 Million	634,597 Added 80.98%	1,418,286 $17.8 Million
Q3 2018 Nov 14, 2018	SELL	$9.55 - $12.64 $746,303 - $987,778	-78,147 Reduced 9.07%	783,689 $7.48 Million
Q2 2018 Aug 14, 2018	BUY	$5.39 - $9.66 $733,557 - $1.31 Million	136,096 Added 18.75%	861,836 $8.05 Million
Q1 2018 May 15, 2018	SELL	$5.44 - $6.97 $299,363 - $383,559	-55,030 Reduced 7.05%	725,740 $4.04 Million
Q4 2017 Feb 14, 2018	BUY	$6.05 - $9.37 $139,688 - $216,343	23,089 Added 3.05%	780,770 $5.1 Million
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $5.92 Million - $6.64 Million	757,681	757,681 $6.65 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account